Profil
David G.
Ichikawa worked as the VP-Finance, Research & Development at Chiron Corp.
from 1994 to 2002.
He then worked as the Senior Vice President-Business Development at Sangamo Therapeutics, Inc. before becoming the Chief Business Officer at Sagres Discovery, Inc. from 2002 to 2004.
Mr. Ichikawa holds an MBA from the University of California, Berkeley and an undergraduate degree from the University of California, Davis.
Anciens postes connus de David G. Ichikawa
| Sociétés | Poste | Fin |
|---|---|---|
Sagres Discovery, Inc.
 Sagres Discovery, Inc. Pharmaceuticals: MajorHealth Technology Sagres Discovery, Inc. researches and discovers oncology treatments. Its technology platform combines the biology of cancer formation in mouse models with the robustness of genomic technologies to enable discovery and clinical validation of human cancer genes. The company is headquartered in Davis, CA. | Corporate Officer/Principal | 01/09/2004 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Directeur Financier/CFO | 01/02/2002 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de David G. Ichikawa
| University of California, Berkeley | Masters Business Admin |
| University of California, Davis | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Sagres Discovery, Inc.
Sagres Discovery, Inc. Pharmaceuticals: MajorHealth Technology Sagres Discovery, Inc. researches and discovers oncology treatments. Its technology platform combines the biology of cancer formation in mouse models with the robustness of genomic technologies to enable discovery and clinical validation of human cancer genes. The company is headquartered in Davis, CA. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |